{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=61", "query": { "intervention": "Control Comparator", "page": 61 }, "page_size": 10 }, "pagination": { "page": 61, "page_size": 10, "total_count": 1671, "total_pages": 168, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=62&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=60&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T03:46:06.965Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02176980", "title": "Hepatitis C Alcohol Reduction Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hepatitis C, Chronic; AUD" ], "interventions": [ { "name": "Brief alcohol counseling", "type": "BEHAVIORAL" }, { "name": "Group and Individual Therapy Sessions", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 182, "start_date": "2014-10", "completion_date": "2018-09-30", "has_results": false, "last_update_posted_date": "2018-10-18", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02176980" }, { "nct_id": "NCT06025396", "title": "Multiple Ascending Dose Study of TMP-301 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cocaine Use Disorder", "Substance Use Disorders", "Healthy Volunteers" ], "interventions": [ { "name": "Cohort 1 - TMP-301", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Cohort 2 - TMP-301", "type": "DRUG" }, { "name": "Cohort 3 - TMP-301", "type": "DRUG" }, { "name": "Cohort 4 - TMP-301", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tempero Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 30, "start_date": "2023-01-06", "completion_date": "2024-01-02", "has_results": true, "last_update_posted_date": "2025-07-29", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06025396" }, { "nct_id": "NCT06752759", "title": "Nebulized Ketamine for the Treatment of Major Depressive Disorder", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Severe Depression", "Moderate Depression", "Ketamine", "Midazolam", "Peripheral Nervous System Agents", "Central Nervous System Agents", "Neurotransmitter Agents", "Physiologic Effects of Drugs", "Sensory System Agents", "Analgesics, Non-Narcotic", "Anti-Inflammatory Agents, Non-Steroidal", "Depressive Symptom", "Hypnotics and Sedatives", "Anti-anxiety Agents", "Tranquilizing Agents", "Psychotropic Drugs", "Anesthetics Agent" ], "interventions": [ { "name": "nebulized ketamine", "type": "DRUG" }, { "name": "nebulized midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Theresa Jacob, PhD, MPH", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "88 Years", "sex": "ALL", "summary": "18 Years to 88 Years" }, "enrollment_count": 40, "start_date": "2024-10-16", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 1, "location_summary": "Brooklyn, New York", "locations": [ { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06752759" }, { "nct_id": "NCT04800562", "title": "A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Necrobiosis Lipoidica" ], "interventions": [ { "name": "PCS499", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Processa Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 4, "start_date": "2021-04-12", "completion_date": "2023-04-14", "has_results": false, "last_update_posted_date": "2023-08-03", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 4, "location_summary": "San Diego, California • Rochester, Minnesota • Charleston, South Carolina + 1 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04800562" }, { "nct_id": "NCT03273062", "title": "A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Brain Injuries", "Brain Injuries, Traumatic", "Brain Injury, Chronic" ], "interventions": [ { "name": "Tolcapone 200 MG", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Sheppard Pratt Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 16, "start_date": "2017-07-20", "completion_date": "2018-07-20", "has_results": false, "last_update_posted_date": "2017-09-06", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 1, "location_summary": "Towson, Maryland", "locations": [ { "city": "Towson", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03273062" }, { "nct_id": "NCT03275740", "title": "A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy", "Primary Immune Thrombocytopenia", "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating" ], "interventions": [ { "name": "PF-06755347 intravenous healthy participant", "type": "DRUG" }, { "name": "Placebo intravenous healthy participant", "type": "DRUG" }, { "name": "PF-06755347 subcutaneous healthy participant", "type": "DRUG" }, { "name": "Placebo subcutaneous healthy participant", "type": "DRUG" }, { "name": "PF-06755347 subcutaneous ITP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 58, "start_date": "2017-07-17", "completion_date": "2023-01-06", "has_results": true, "last_update_posted_date": "2024-07-05", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03275740" }, { "nct_id": "NCT06117280", "title": "Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Energy", "Focus", "Caffeine Withdrawal" ], "interventions": [ { "name": "Paraxanthine 200 mg", "type": "OTHER" }, { "name": "Paraxanthine 300 mg", "type": "OTHER" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Iovate Health Sciences International Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 45, "start_date": "2023-07-18", "completion_date": "2023-10-20", "has_results": false, "last_update_posted_date": "2023-11-07", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 1, "location_summary": "Santa Monica, California", "locations": [ { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06117280" }, { "nct_id": "NCT02421874", "title": "Development and Testing of an Electronic Behavioral Health Record Specific to the Wraparound Care Coordination Process", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Serious Emotional Disturbance of Youth" ], "interventions": [ { "name": "Wraparound Team Monitoring System electronic health record", "type": "BEHAVIORAL" }, { "name": "Education about fidelity maintenance and monitoring", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2015-07", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2016-10-26", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT02421874" }, { "nct_id": "NCT01464320", "title": "A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine" ], "interventions": [ { "name": "ABT-614", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "19 Years to 70 Years" }, "enrollment_count": 16, "start_date": "2011-11", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2012-08-22", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01464320" }, { "nct_id": "NCT05923749", "title": "A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Wound Heal" ], "interventions": [ { "name": "Biatain Ag", "type": "DEVICE" }, { "name": "Cutimed Siltec Sorbact", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Coloplast A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2023-06-29", "completion_date": "2025-01-29", "has_results": false, "last_update_posted_date": "2025-05-22", "last_synced_at": "2026-10-28T03:46:06.965Z", "location_count": 5, "location_summary": "Hollywood, Florida • North Port, Florida • Clinton Township, Michigan + 2 more", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "North Port", "state": "Florida" }, { "city": "Clinton Township", "state": "Michigan" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Monroeville", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05923749" } ] }